Autor: "Rankin EB" - OpacWWW

Skocz do pozycji: 1.

Tytuł:: Targeting integrins with RGD-conjugated gold nanoparticles in radiotherapy decreases the invasive activity of breast cancer cells
Autorzy:: Wu PH
Onodera Y
Ichikawa Y
Rankin EB
Giaccia AJ
Watanabe Y
Qian W
Hashimoto T
Shirato H
Nam JM; Pokaż więcej
Temat:: gold nanoparticles
radiotherapy
breast cancer
invasion
integrin
fibronectin
Medicine (General)
R5-920
Źródło:: International Journal of Nanomedicine, Vol Volume 12, Pp 5069-5085 (2017)
Opis pliku:: electronic resource
Relacje:: https://www.dovepress.com/targeting-integrins-with-rgd-conjugated-gold-nanoparticles-in-radiothe-peer-reviewed-article-IJN; https://doaj.org/toc/1178-2013
Dostęp URL:: https://doaj.org/article/7fd4df3235b342629994a93a747c4311 Link otwiera się w nowym oknie

Czasopismo naukowe

na półce

Szczegóły

Skocz do pozycji: 2.

Tytuł:: Abdominal FLASH irradiation reduces radiation-induced gastrointestinal toxicity for the treatment of ovarian cancer in mice.
Autorzy:: Levy K; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Natarajan S; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Wang J; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Chow S; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Eggold JT; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Loo PE; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Manjappa R; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Melemenidis S; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Lartey FM; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Schüler E; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Skinner L; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Rafat M; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Department of Chemical and Biomolecular Engineering, Vanderbilt University School of Engineering, Nashville, TN, 37235, USA.
Ko R; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Kim A; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
H Al-Rawi D; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
von Eyben R; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Dorigo O; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Casey KM; Department of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Graves EE; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Bush K; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Yu AS; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA.
Koong AC; Division of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.
Maxim PG; Department of Radiation Oncology, Indiana University School of Medicine, Indianapolis, IN, 46202, USA.
Loo BW Jr; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA. .; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. .
Rankin EB; Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, 94305, USA. .; Department of Obstetrics and Gynecology, Stanford University School of Medicine, Stanford, CA, 94305, USA. .; Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, 94305, USA. .; Pokaż więcej
Źródło:: Scientific reports [Sci Rep] 2020 Dec 10; Vol. 10 (1), pp. 21600. Date of Electronic Publication: 2020 Dec 10.
Typ publikacji:: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:: Gastrointestinal Tract/*radiation effects
Ovarian Neoplasms/*radiotherapy
Radiation Injuries, Experimental/*prevention & control
Radiotherapy/*methods
Animals ; Female ; Gastrointestinal Tract/injuries ; Gastrointestinal Tract/pathology ; Mice ; Mice, Inbred C57BL ; Radiotherapy/adverse effects

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 3.

Tytuł:: Omental macrophages secrete chemokine ligands that promote ovarian cancer colonization of the omentum via CCR1.
Autorzy:: Krishnan V; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.
Tallapragada S; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.
Schaar B; Genome Technology Center, Stanford, CA, USA.
Kamat K; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.
Chanana AM; Department of Obstetrics and Gynecology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA.
Zhang Y; Department of Physiology and Chemistry, Genentech, San Francisco, CA, USA.
Patel S; Department of Thoracic Head and Neck Medical Oncology, Division of Cancer Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
Parkash V; Department of Pathology, Yale School of Medicine and Yale School of Public Health, New Haven, CT, USA.
Rinker-Schaeffer C; Department of Surgery, Division of Urology, University of Chicago, Chicago, IL, USA.
Folkins AK; Department of Pathology, Stanford School of Medicine, Stanford, CA, USA.
Rankin EB; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.; Department of Radiation Oncology, Stanford School of Medicine, Stanford, CA, USA.
Dorigo O; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Stanford School of Medicine, Stanford Cancer Institute, Stanford, CA, USA. .; Stanford Women's Cancer Center, Stanford, CA, USA. .; Pokaż więcej
Źródło:: Communications biology [Commun Biol] 2020 Sep 22; Vol. 3 (1), pp. 524. Date of Electronic Publication: 2020 Sep 22.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms:: Chemokines/*metabolism
Macrophages/*metabolism
Omentum/*pathology
Ovarian Neoplasms/*pathology
Peritoneal Neoplasms/*secondary
Receptors, CCR1/*metabolism
Animals ; CRISPR-Associated Protein 9 ; CRISPR-Cas Systems ; Cell Line, Tumor ; Chemokines, CC/metabolism ; Female ; Flow Cytometry ; Gene Editing ; Gene Knockdown Techniques ; Humans ; Mice ; Mice, Inbred C57BL ; Neoplasm Transplantation ; Ovarian Neoplasms/metabolism ; Peritoneal Neoplasms/metabolism ; Real-Time Polymerase Chain Reaction ; Transcriptome

Czasopismo naukowe

na półce

Pełny tekst Pełny tekst Szczegóły

Skocz do pozycji: 4.

Tytuł:: The Receptor Tyrosine Kinase AXL in Cancer Progression.
Autorzy:: Rankin EB; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA. .; Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, CA 94305, USA. .
Giaccia AJ; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305, USA. .; Pokaż więcej
Źródło:: Cancers [Cancers (Basel)] 2016 Nov 09; Vol. 8 (11). Date of Electronic Publication: 2016 Nov 09.
Typ publikacji:: Review; Journal Article

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 5.

Tytuł:: Hypoxic control of metastasis.
Autorzy:: Rankin EB; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305-5152, USA. Department of Obstetrics and Gynecology, Stanford University Medical Center, Stanford, CA 94305-5152, USA.
Giaccia AJ; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University Medical Center, Stanford, CA 94305-5152, USA. .; Pokaż więcej
Źródło:: Science (New York, N.Y.) [Science] 2016 Apr 08; Vol. 352 (6282), pp. 175-80. Date of Electronic Publication: 2016 Apr 07.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
MeSH Terms:: Tumor Microenvironment*
Basic Helix-Loop-Helix Transcription Factors/*metabolism
Hypoxia-Inducible Factor 1, alpha Subunit/*metabolism
Neoplasm Metastasis/*pathology
Neoplasm Metastasis/*therapy
Animals ; Biomarkers, Tumor/analysis ; Biomarkers, Tumor/metabolism ; Cell Hypoxia ; Cell Movement ; Disease Progression ; Drug Resistance, Neoplasm ; Epithelial-Mesenchymal Transition ; Humans ; Neoplasm Invasiveness ; Radiation Tolerance ; Signal Transduction

Czasopismo naukowe

na półce

Pełny tekst Szczegóły

Skocz do pozycji: 6.

Tytuł:: CTGF is a therapeutic target for metastatic melanoma.
Autorzy:: Finger EC; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Cheng CF; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Williams TR; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Rankin EB; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Bedogni B; Department of Biochemistry, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
Tachiki L; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Spong S; FibroGen Inc., San Francisco, CA, USA.
Giaccia AJ; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.
Powell MB; Division of Radiation and Cancer Biology, Department of Radiation Oncology, Stanford University, Stanford, CA, USA.; Pokaż więcej
Źródło:: Oncogene [Oncogene] 2014 Feb 27; Vol. 33 (9), pp. 1093-100. Date of Electronic Publication: 2013 Feb 25.
Typ publikacji:: Journal Article; Research Support, N.I.H., Extramural
MeSH Terms:: Connective Tissue Growth Factor/*antagonists & inhibitors
Connective Tissue Growth Factor/*genetics
Melanoma/*drug therapy
Melanoma/*genetics
Animals ; Antibodies, Monoclonal/pharmacology ; Antibodies, Monoclonal, Humanized ; Basic Helix-Loop-Helix Transcription Factors/genetics ; Cell Line, Tumor ; Disease Progression ; Gene Expression Regulation, Neoplastic/drug effects ; Gene Expression Regulation, Neoplastic/genetics ; Humans ; Hypoxia/genetics ; Hypoxia-Inducible Factor 1/genetics ; Matrix Metalloproteinase 9/genetics ; Melanoma/pathology ; Mice ; Mice, SCID